Moderna, Inc. (MRNA) FY2025 Q1 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2025-03-31

Swipe to see the full flow
Moderna, Inc. (MRNA) FY2025 Q1 Balance SheetBalance sheet as of 2025-03-31. The chart shows assets, liabilities and equity at that date.Current liabilities$1.60 BLiabilities$2.64 BCurrent assets$6.77 BAssets$12.70 BNon-current liabilities$1.03 BEquity$10.07 BNon-current assets$5.94 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSInvestmentsCash and cash equivalentsPrepaid expenses and other current assetsInventoryAccounts receivable, netInvestments, non-currentProperty, plant and equipment, netRight-of-use assets, operating leasesOther non-current assetsAccrued liabilitiesOther current liabilitiesAccounts payableDeferred revenueOperating lease liabilities, non-currentOther non-current liabilitiesDeferred revenue, non-currentFinancing lease liabilities, non-currentRetained earningsAdditional paid-in capitalAccumulated other comprehensive income (loss)Current assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityAccrued liabilitiesAccrued liabilities$1.00 BCurrent liabilitiesCurrent liabilities$1.60 BOther current liabilitiesOther current liabilities$252.00 MAccounts payableAccounts payable$226.00 MLiabilitiesLiabilities$2.64 BCurrent assetsCurrent assets$6.77 BInvestmentsInvestments$4.35 BDeferred revenueDeferred revenue$125.00 MAssetsAssets$12.70 BOperating lease liabilities, non-currentOperating lease liabilities, non-current$667.00 MCash and cash equivalentsCash and cash equivalents$1.62 BNon-current liabilitiesNon-current liabilities$1.03 BOther non-current liabilitiesOther non-current liabilities$274.00 MPrepaid expenses and other current assetsPrepaid expenses and other current assets$585.00 MDeferred revenue, non-currentDeferred revenue, non-current$58.00 MInventoryInventory$128.00 MFinancing lease liabilities, non-currentFinancing lease liabilities, non-current$35.00 MEquityEquity$10.07 BAccounts receivable, netAccounts receivable, net$78.00 MNon-current assetsNon-current assets$5.94 BInvestments, non-currentInvestments, non-current$2.42 BRetained earningsRetained earnings$9.07 BProperty, plant and equipment, netProperty, plant and equipment, net$2.21 BRight-of-use assets, operating leasesRight-of-use assets, operating leases$752.00 MOther non-current assetsOther non-current assets$556.00 MAdditional paid-in capitalAdditional paid-in capital$982.00 MAccumulated other comprehensive income (loss)Accumulated other comprehensive income (loss)$10.00 M
Chart details

Moderna, Inc. (MRNA) FY2025 Q1 Balance Sheet

Balance sheet as of 2025-03-31. The chart shows assets, liabilities and equity at that date.

Assets
12,704,000,000 US dollars
Current assets
6,766,000,000 US dollars
Non-current assets
5,938,000,000 US dollars
Liabilities
2,638,000,000 US dollars
Current liabilities
1,604,000,000 US dollars
Non-current liabilities
1,034,000,000 US dollars
Equity
10,066,000,000 US dollars
Investments
4,352,000,000 US dollars
Cash and cash equivalents
1,623,000,000 US dollars
Prepaid expenses and other current assets
585,000,000 US dollars
Inventory
128,000,000 US dollars
Accounts receivable, net
78,000,000 US dollars
Investments, non-current
2,418,000,000 US dollars
Property, plant and equipment, net
2,212,000,000 US dollars
Right-of-use assets, operating leases
752,000,000 US dollars
Other non-current assets
556,000,000 US dollars
Accrued liabilities
1,001,000,000 US dollars
Other current liabilities
252,000,000 US dollars
Accounts payable
226,000,000 US dollars
Deferred revenue
125,000,000 US dollars
Operating lease liabilities, non-current
667,000,000 US dollars
Other non-current liabilities
274,000,000 US dollars
Deferred revenue, non-current
58,000,000 US dollars
Financing lease liabilities, non-current
35,000,000 US dollars
Retained earnings
9,074,000,000 US dollars
Additional paid-in capital
982,000,000 US dollars
Accumulated other comprehensive income (loss)
10,000,000 US dollars
Preferred stock, par value $0.0001; 162 shares authorized as of March 31, 2025 and December 31, 2024; no shares issued or outstanding at March 31, 2025 and December 31, 2024
0 US dollars
Common stock, par value $0.0001; 1,600 shares authorized as of March 31, 2025 and December 31, 2024; 387 and 386 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively
0 US dollars

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
Moderna, Inc. (MRNA) FY2025 Q1 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!